Pharma Grade Chondroitin Sulfate Market

Chondroitin Sulfate is a Sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be Sulfated in variable positions and quantities. Chondroitin Sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin Sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
Pharma Grade Chondroitin Sulfate Market contains market size and forecasts of Pharma Grade Chondroitin Sulfate in global, including the following market information:
Global Pharma Grade Chondroitin Sulfate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pharma Grade Chondroitin Sulfate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Pharma Grade Chondroitin Sulfate companies in 2021 (%)
The global Pharma Grade Chondroitin Sulfate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharma Grade Chondroitin Sulfate include TSI, Yantai Dongcheng, Focus Chem, IBSA, Runxin Biotechnology, QJBCHINA, Jiaxing Hengjie and Pacific Rainbow, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Grade Chondroitin Sulfate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma Grade Chondroitin Sulfate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pharma Grade Chondroitin Sulfate Market Segment Percentages, by Type, 2021 (%)
Powder
Solution
Global Pharma Grade Chondroitin Sulfate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pharma Grade Chondroitin Sulfate Market Segment Percentages, by Application, 2021 (%)
Anticoagulant
Antithrombotic
Global Pharma Grade Chondroitin Sulfate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pharma Grade Chondroitin Sulfate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Grade Chondroitin Sulfate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pharma Grade Chondroitin Sulfate revenues share in global market, 2021 (%)
Key companies Pharma Grade Chondroitin Sulfate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Pharma Grade Chondroitin Sulfate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
TSI
Yantai Dongcheng
Focus Chem
IBSA
Runxin Biotechnology
QJBCHINA
Jiaxing Hengjie
Pacific Rainbow